|
|||||
|
|
COVID-19 and fibrosis: Mechanisms,clinical relevance,and future perspectives |
|
| Affiliation: | 1. Department of Biological Sciences (Regulatory Toxicology), National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500 037, India;2. Department of Internal Medicine, Oncology Division, Washington University, School of Medicine, St Louis, MO 63110, USA |
| Abstract: | |
| Keywords: | COVID-19 SARS-CoV-2 Fibrosis Extracellular matrix Antifibrotic agents |
| 本文献已被 ScienceDirect 等数据库收录！ | |